Wealthspring Capital’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Wealthspring Capital’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28,978	Closed	-$292K	–	205
2022 Q4	$292K	Sell	28,978 -149,287	-84%	-$1.49M	0.44%	79
2022 Q3	$1.76M	Sell	178,265 -10,223	-5%	-$101K	0.35%	76
2022 Q2	$1.84M	Buy	188,488 +51,855	+38%	+$508K	0.35%	69
2022 Q1	$1.34M	Buy	136,633 +10,351	+8%	+$101K	0.26%	135
2021 Q4	$1.22M	Sell	126,282 -15,126	-11%	-$147K	0.26%	141
2021 Q3	$1.38M	Buy	141,408 +23,960	+20%	+$231K	0.33%	106
2021 Q2	$1.13M	Buy	+117,448	New	+$1.15M	0.28%	119

Wealthspring Capital's MSAC Position: Q1 2023 in Review

Wealthspring Capital sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 28,978 shares — an estimated $292K sold.

Wealthspring Capital first reported a position in MSAC in Q2 2021 and held it in 7 quarters. The position peaked at $1.84M in Q2 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Wealthspring Capital reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Wealthspring Capital sold 28,978 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $292K.
Wealthspring Capital first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q2 2021 and held it in 7 quarters.
Wealthspring Capital's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $1.84M in Q2 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Wealthspring Capital's 13F filing for Q1 2023, filed 25 Apr 2023.